The Effects of Antimicrobial Mouthwashes on Systemic Disease: What Is the Evidence?


Journal

International dental journal
ISSN: 1875-595X
Titre abrégé: Int Dent J
Pays: England
ID NLM: 0374714

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 09 08 2023
accepted: 21 08 2023
medline: 24 11 2023
pubmed: 23 10 2023
entrez: 22 10 2023
Statut: ppublish

Résumé

The potential association between antimicrobial mouthwash use and systemic health has gained attention in recent years with reports highlighting how some common systemic conditions are influenced by the use of different types of mouthwashes. In this context, links between mouthwash use and cardiovascular disease, diabetes mellitus, oral cancer, Alzheimer's disease, and preeclampsia have been proposed, albeit with limited levels of evidence. Chlorhexidine mouthwash in particular has been the most widely studied agent while available data on other types of over-the-counter mouthwashes are generally scarce. Furthermore, there is currently no evidence-based recommendations on the appropriate use of mouthwashes during pregnancy. This article will present the current evidence on the association between mouthwash use and the aforementioned conditions with emphasis on the mechanisms that may underlie such an association.

Identifiants

pubmed: 37867067
pii: S0020-6539(23)00459-8
doi: 10.1016/j.identj.2023.08.012
pmc: PMC10690546
pii:
doi:

Substances chimiques

Mouthwashes 0
Chlorhexidine R4KO0DY52L
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S82-S88

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None disclosed.

Références

Clin Oral Investig. 2018 Nov;22(8):2943-2946
pubmed: 30151707
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Front Microbiol. 2020 Sep 15;11:555465
pubmed: 33042063
Periodontol 2000. 2020 Jun;83(1):242-271
pubmed: 32385876
Eur J Neurol. 2018 Jan;25(1):59-70
pubmed: 28872215
Br Dent J. 2023 Feb 3;:
pubmed: 36737459
Hypertension. 2017 Jul 31;:
pubmed: 28760940
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancers (Basel). 2018 Jan 14;10(1):
pubmed: 29342885
Curr Hypertens Rep. 2017 Apr;19(4):33
pubmed: 28353075
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
Cardiovasc Res. 2017 Jul 1;113(9):1009-1023
pubmed: 28838042
BMJ. 2019 Jul 15;366:l2381
pubmed: 31307997
BMC Cancer. 2014 Mar 14;14:187
pubmed: 24629046
J Clin Med. 2020 Feb 11;9(2):
pubmed: 32054121
Anticancer Res. 2018 Jun;38(6):3223-3229
pubmed: 29848669
Free Radic Biol Med. 2013 Feb;55:93-100
pubmed: 23183324
Am J Dent. 2015 Sep;28 Spec No A:4A-8A
pubmed: 26591619
Int J Environ Res Public Health. 2021 Sep 03;18(17):
pubmed: 34501899
Br Dent J. 2014 Apr;216(8):457-61
pubmed: 24762896
Cochrane Database Syst Rev. 2017 Mar 31;3:CD008676
pubmed: 28362061
Evid Based Dent. 2016 Mar;17(1):8-9
pubmed: 27012566
Nat Rev Dis Primers. 2023 Feb 16;9(1):8
pubmed: 36797292
Crit Care. 2009;13(4):218
pubmed: 19664175
Mediators Inflamm. 2015;2015:137357
pubmed: 26063967
J Hum Hypertens. 2005 Jun;19(6):457-62
pubmed: 15759024
Eur J Hum Genet. 2019 Jan;27(1):102-113
pubmed: 30218097
JAMA Netw Open. 2022 Dec 1;5(12):e2247632
pubmed: 36534397
Alcohol Clin Exp Res. 2018 Nov;42(11):2100-2106
pubmed: 30144114
Novartis Found Symp. 2007;285:80-9; discussion 89-96, 198-9
pubmed: 17590988
Nitric Oxide. 2017 Dec 1;71:14-20
pubmed: 28939409
Food Chem Toxicol. 1991 Nov;29(11):751-5
pubmed: 1761254
PLoS One. 2016 Mar 10;11(3):e0151081
pubmed: 26963387
JAMA Intern Med. 2014 May;174(5):751-61
pubmed: 24663255
Atherosclerosis. 2014 Sep;236(1):39-46
pubmed: 25014033
Eur J Cancer Prev. 2016 Jul;25(4):344-8
pubmed: 26275006
Evid Based Dent. 2022 Mar;23(1):28-29
pubmed: 35338325
Matern Child Health J. 2022 Dec;26(12):2419-2443
pubmed: 36209308
Adv Dent Res. 2011 May;23(2):237-46
pubmed: 21490236
Sci Rep. 2020 Mar 24;10(1):5254
pubmed: 32210245
Am J Clin Nutr. 2018 Apr 1;107(4):504-522
pubmed: 29635489
Science. 2023 Jan 13;379(6628):eadd1236
pubmed: 36634180
Intensive Care Med. 2021 Jan;47(1):28-38
pubmed: 33067640
Front Cell Infect Microbiol. 2019 Mar 01;9:39
pubmed: 30881924
J Nutr. 2013 Jun;143(6):818-26
pubmed: 23596162
Nat Rev Immunol. 2021 Jul;21(7):426-440
pubmed: 33510490
J Biomech Eng. 2019 Mar 1;141(3):
pubmed: 30383187
J Oral Maxillofac Res. 2012 Oct 01;3(3):e1
pubmed: 24422013
Surg Infect (Larchmt). 2020 Oct;21(8):659-664
pubmed: 31928384
Healthcare (Basel). 2022 Apr 20;10(5):
pubmed: 35627901
Oral Dis. 2015 Sep;21(6):748-54
pubmed: 25809116
Oral Oncol. 2014 Jun;50(6):616-25
pubmed: 24680035
BMJ. 2014 Mar 31;348:g2197
pubmed: 24687313
Blood Press. 2020 Apr;29(2):103-112
pubmed: 31709856
Clin Oral Investig. 2021 Mar;25(3):797-806
pubmed: 33469718

Auteurs

Mohammad S Alrashdan (MS)

Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, UAE; Department of Oral Medicine and Oral Surgery, Faculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan.

Jair Carneiro Leao (JC)

Universidade Federal de Pernambuco, Programa de Pós-Graduação em Odontologia, Recife PE, Brazil.

Amazon Doble (A)

Peninsula Dental School, Plymouth University, Portland Square, Plymouth, UK.

Michael McCullough (M)

Melbourne Dental School, The University of Melbourne, Melbourne, Australia. Electronic address: m.mccullough@unimelb.edu.au.

Stephen Porter (S)

UCL Eastman Dental Institute, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH